In pancreatic cancer, CHMP4C facilitates progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway, thereby emphasizing its role in cell survival and proliferation (Yu et al., 2025). Here, RIPK1 is linked to pancreatic neoplasm.